Tunstall Demonstrates Latest Innovations in Telehealthcare at Commissioning 2013

TunstallTunstall Healthcare, the leading provider of telehealth and telecare solutions, is showcasing its latest innovations to transform healthcare by supporting patient self-management and successfully delivering telehealth at scale at Commissioning 2013.

Tunstall's key focus at the event is its 5 Steps to Telehealth Success programme, a robust implementation process which helps health providers to ensure that telehealth is deployed successfully to the right patients, and embedded within care pathways. Tunstall provides dedicated, clinical support throughout the telehealth journey, from engagement to deployment and governance.

The 5 step approach covers care pathway optimisation, patient identification and risk stratification, clinical review and care planning, referral generation, and post-deployment review and support. This ensures positive outcomes for patients and clinicians, and accelerates financial returns.

Tunstall will also be demonstrating its latest mymedic II home telehealth system, which is designed to help people with long-term health needs to monitor their own conditions from home. The device enables users to easily self-monitor their vital signs to ensure timely intervention, while enhancing understanding of their health.

Designed specifically for the needs of patients with poor dexterity and eyesight, the system's touchscreen tablet design gives easy access to functions and offers limitless flexibility for future applications, while Bluetooth technology makes the process of sharing information faster and more efficient. New peripherals for mymedic II include a blood pressure monitor, pulse oximeter and weighing scales, enabling the solution to help manage a range of long-term conditions.

Tunstall is working together with risk stratification provider Health Intelligence to enhance and support the delivery of its fully managed telehealthcare service, Tunstall LifeCare. A proven risk stratification process is essential for delivering an effective telehealthcare service at scale, as it identifies the most appropriate patients for the service, accelerating benefits to service users and maximising care provision and ROI for the provider.

Tunstall LifeCare and Health Intelligence’s population-based Risk Stratification and Case Finding modules offer local commissioners a robust, secure and rapidly deployable solution that helps the NHS to improve diagnosis, promote prevention and deliver cost savings.

David Cockayne, Managed Services Director said: "For telehealth programmes to be truly successful at scale, it's important that each patient is carefully selected based on specific criteria and thresholds. Commissioning 2013 is a great opportunity for us to showcase how our advanced solutions and services and our partnership with Health Intelligence can help commissioners and clinicians in identifying the patients who will benefit most from telehealth, and deliver the most positive outcomes for patients, clinicians and commissioners."

Related news articles:

About Tunstall
Tunstall Healthcare Group is the market leading provider of telehealthcare solutions, with over 2.5 million users globally. Tunstall’s solutions support older people and those with long-term needs, helping them to live independently by effectively managing their health and well-being. Its solutions have been proven effective in the world's largest telehealthcare trial. Tunstall provides technology, expertise and advice to millions of people enabling them to lead independent more fulfilling lives.

Most Popular Now

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...